Why is there still no licensed vaccine for Bundibugyo ebolavirus? Lessons from the 2026 outbreaks in Uganda and the Democratic Republic of Congo. [PDF]
New Microbes New InfectAbdi AM +4 more
europepmc +1 more source
Ebola Virus Disease in the Era of One Health and Global Preparedness: Evolving Epidemiology, Genomic Surveillance, and Future Challenges. [PDF]
Infect Dis RepDe Maria F +8 more
europepmc +1 more source
Zaire ebolavirus membrane associated protein (VP24); Z. ebolavirus polymerase complex protein (VP35); Z. ebolavirus L polymerase [PDF]
Science-Business eXchange, 2010 openaire +1 more source
Ebola Bundibugyo resurgence in eastern Democratic Republic of Congo: Implications for regional surveillance and preparedness. [PDF]
J Virus EradMohammed AA +4 more
europepmc +1 more source
<i>R</i> <sub>0</sub> of Bundibugyo virus disease and the critical issue of case ascertainment in the Democratic Republic of the Congo. [PDF]
New Microbes New InfectFujiwara S, Nishiura H.
europepmc +1 more source
Rapid Geographic Expansion, Decelerating Growth, and Six-Month Scenario Projections of Bundibugyo Virus Disease in the Democratic Republic of the Congo: Analysis of Situation Reports 1-61. [PDF]
VirusesMwenebitu DL +9 more
europepmc +1 more source
Design of Epitope-Focused Vaccines via Epitope Cleavage. [PDF]
ACS Cent SciPham DM, Costello RM, Bruun TUJ, Kim PS.
europepmc +1 more source
Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing. [PDF]
J Antimicrob ChemotherPetit PR +13 more
europepmc +1 more source